Wang YX - Search Results

1

HOCl oxidation-modified CT26 cell vaccine inhibits colon tumor growth in a mouse model.

Zhou R, Huang WJ, Ma C, Zhou Y, Yao YQ, Wang YX, Gou LT, Yi C, Yang JL. Zhou R, et al. Among authors: wang yx. Asian Pac J Cancer Prev. 2012;13(8):4037-43. doi: 10.7314/apjcp.2012.13.8.4037. Asian Pac J Cancer Prev. 2012. PMID: 23098513 Free article.

2

Isoliquiritigenin inhibits the growth of multiple myeloma via blocking IL-6 signaling.

Chen X, Wu Y, Jiang Y, Zhou Y, Wang Y, Yao Y, Yi C, Gou L, Yang J. Chen X, et al. J Mol Med (Berl). 2012 Nov;90(11):1311-9. doi: 10.1007/s00109-012-0910-3. Epub 2012 May 31. J Mol Med (Berl). 2012. PMID: 22648519

3

Synthesis, characterization, and antitumor evaluation of the albumin-SN38 conjugate.

Yao Y, Su X, Xie Y, Wang Y, Kang T, Gou L, Yi C, Yang J. Yao Y, et al. Anticancer Drugs. 2013 Mar;24(3):270-7. doi: 10.1097/CAD.0b013e32835c3543. Anticancer Drugs. 2013. PMID: 23233044

4

CA II, a potential biomarker by proteomic analysis, exerts significant inhibitory effect on the growth of colorectal cancer cells.

Zhou R, Huang W, Yao Y, Wang Y, Li Z, Shao B, Zhong J, Tang M, Liang S, Zhao X, Tong A, Yang J. Zhou R, et al. Int J Oncol. 2013 Aug;43(2):611-21. doi: 10.3892/ijo.2013.1972. Epub 2013 May 31. Int J Oncol. 2013. PMID: 23727877

5

Eradication of growth of HER2-positive ovarian cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate in mouse xenograft model.

Yu L, Wang Y, Yao Y, Li W, Lai Q, Li J, Zhou Y, Kang T, Xie Y, Wu Y, Chen X, Yi C, Gou L, Yang J. Yu L, et al. Int J Gynecol Cancer. 2014 Sep;24(7):1158-64. doi: 10.1097/IGC.0000000000000179. Int J Gynecol Cancer. 2014. PMID: 24987913

6

Isoliquiritigenin prevents the progression of psoriasis-like symptoms by inhibiting NF-κB and proinflammatory cytokines.

Wu Y, Chen X, Ge X, Xia H, Wang Y, Su S, Li W, Yang T, Wei M, Zhang H, Gou L, Li J, Jiang X, Yang J. Wu Y, et al. J Mol Med (Berl). 2016 Feb;94(2):195-206. doi: 10.1007/s00109-015-1338-3. Epub 2015 Sep 18. J Mol Med (Berl). 2016. PMID: 26383911

7

Synthesis, characterization and targeting chemotherapy for ovarian cancer of trastuzumab-SN-38 conjugates.

Yao Y, Yu L, Su X, Wang Y, Li W, Wu Y, Cheng X, Zhang H, Wei X, Chen H, Zhang R, Gou L, Chen X, Xie Y, Zhang B, Zhang Y, Yang J, Wei Y. Yao Y, et al. J Control Release. 2015 Dec 28;220(Pt A):5-17. doi: 10.1016/j.jconrel.2015.09.058. Epub 2015 Oct 9. J Control Release. 2015. PMID: 26439663

8

Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery.

Wang Y, Zhang H, Gigant B, Yu Y, Wu Y, Chen X, Lai Q, Yang Z, Chen Q, Yang J. Wang Y, et al. FEBS J. 2016 Jan;283(1):102-11. doi: 10.1111/febs.13555. Epub 2015 Nov 4. FEBS J. 2016. PMID: 26462166 Free article.

9

Structural Insights into the Pharmacophore of Vinca Domain Inhibitors of Microtubules.

Wang Y, Benz FW, Wu Y, Wang Q, Chen Y, Chen X, Li H, Zhang Y, Zhang R, Yang J. Wang Y, et al. Mol Pharmacol. 2016 Feb;89(2):233-42. doi: 10.1124/mol.115.100149. Epub 2015 Dec 9. Mol Pharmacol. 2016. PMID: 26660762

10

Pironetin reacts covalently with cysteine-316 of α-tubulin to destabilize microtubule.

Yang J, Wang Y, Wang T, Jiang J, Botting CH, Liu H, Chen Q, Yang J, Naismith JH, Zhu X, Chen L. Yang J, et al. Nat Commun. 2016 Jun 30;7:12103. doi: 10.1038/ncomms12103. Nat Commun. 2016. PMID: 27357539 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,896 results

Search Page

Filters